Skip to content
DataLookout
Menu

NCT07933497

M4 Receptor PET Radioligand Validation Study in Healthy Adults

StatusNot Yet Recruiting
PhaseEarly Phase 1
SponsorAbbVie
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Regional brain volume of distribution (VT) of ABBV-112i across brain regions
Timeframe: Up to Approximately Up to Day 1

Arms and interventions

[11C]ABBV-112iExperimental

Participants will receive two single intravenous bolus doses of \[11C\]ABBV-112i, with each dose followed by up to approximately 90 minutes dynamic PET scan.

Drugs: [11C]ABBV-112i